Efficient disruption of bcr-abl gene by CRISPR RNA-guided FokI nucleases depresses the oncogenesis of chronic myeloid leukemia cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficient disruption of bcr-abl gene by CRISPR RNA-guided FokI nucleases depresses the oncogenesis of chronic myeloid leukemia cells
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-28
DOI
10.1186/s13046-019-1229-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Induction of apoptosis in imatinib sensitive and resistant chronic myeloid leukemia cells by efficient disruption of bcr-abl oncogene with zinc finger nucleases
- (2018) Ningshu Huang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK-ERK and NF-κB pathways in a model of chronic myeloid leukemia
- (2018) Anna Chorzalska et al. Molecular Oncology
- Paired D10A Cas9 nickases are sometimes more efficient than individual nucleases for gene disruption
- (2018) Ramu Gopalappa et al. NUCLEIC ACIDS RESEARCH
- Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 with improved proof-reading enhances homology-directed repair
- (2018) Tomoko Kato-Inui et al. NUCLEIC ACIDS RESEARCH
- Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics
- (2017) S Reckel et al. LEUKEMIA
- Re-engineered RNA-Guided FokI-Nucleases for Improved Genome Editing in Human Cells
- (2017) Steven Havlicek et al. MOLECULAR THERAPY
- Damage-induced lncRNAs control the DNA damage response through interaction with DDRNAs at individual double-strand breaks
- (2017) Flavia Michelini et al. NATURE CELL BIOLOGY
- Precision genome editing using synthesis-dependent repair of Cas9-induced DNA breaks
- (2017) Alexandre Paix et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
- (2017) Eunji Kim et al. Nature Communications
- The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia
- (2017) Ignacio García-Tuñón et al. Oncotarget
- Inhibition of YAP suppresses CML cell proliferation and enhances efficacy of imatinib in vitro and in vivo
- (2016) Hui Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia
- (2016) J L Steegmann et al. LEUKEMIA
- Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?
- (2016) Gianantonio Rosti et al. Nature Reviews Clinical Oncology
- Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining
- (2015) Takeshi Maruyama et al. NATURE BIOTECHNOLOGY
- Therapeutic genome editing: prospects and challenges
- (2015) David Benjamin Turitz Cox et al. NATURE MEDICINE
- Targeting the JAK2-STAT5 pathway in CML
- (2014) P. Valent BLOOD
- Sustained inhibition of STAT5, but not JAK2, is essential for TKI-induced cell death in chronic myeloid leukemia
- (2014) L Schafranek et al. LEUKEMIA
- Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemia
- (2014) A Chorzalska et al. LEUKEMIA
- Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing
- (2014) Shengdar Q Tsai et al. NATURE BIOTECHNOLOGY
- Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease
- (2014) Cem Kuscu et al. NATURE BIOTECHNOLOGY
- Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification
- (2014) John P Guilinger et al. NATURE BIOTECHNOLOGY
- Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity
- (2013) F. Ann Ran et al. CELL
- High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
- (2013) Yanfang Fu et al. NATURE BIOTECHNOLOGY
- CRISPR RNA–guided activation of endogenous human genes
- (2013) Morgan L Maeder et al. NATURE METHODS
- Correcting genetic defects with CRISPR–Cas9
- (2013) Isabel Lokody NATURE REVIEWS GENETICS
- Genome-wide reorganization of histone H2AX toward particular fragile sites on cell activation
- (2013) J. Seo et al. NUCLEIC ACIDS RESEARCH
- Damage-induced DNA replication stalling relies on MAPK-activated protein kinase 2 activity
- (2013) F. Kopper et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MEK-Dependent Negative Feedback Underlies BCR-ABL-Mediated Oncogene Addiction
- (2013) J. Asmussen et al. Cancer Discovery
- Human CML stem cells insensitive to imatinib even when BCR–ABL is inhibited
- (2011) Lisa Hutchinson Nature Reviews Clinical Oncology
- Bcr-Abl-mediated redox regulation of the PI3K/AKT pathway
- (2009) R Naughton et al. LEUKEMIA
- Translation of the Philadelphia chromosome into therapy for CML
- (2008) B. J. Druker BLOOD
- Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase
- (2008) J Cortes et al. LEUKEMIA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now